Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.80% | $3.57M | $41.96B | 205.17% | 81 Outperform | |
| Novartis AG | 4.37% | $2.70M | CHF234.28B | 25.89% | 80 Outperform | |
| Rio Tinto Limited | 4.30% | $2.65M | AU$236.14B | 50.55% | 78 Outperform | |
| Nutrien | 4.26% | $2.63M | C$47.92B | 43.56% | 75 Outperform | |
| BAE Systems | 3.78% | $2.33M | £56.16B | 66.09% | 61 Neutral | |
| Sumitomo Mitsui Financial Group | 3.63% | $2.24M | ¥23.60T | 75.01% | 77 Outperform | |
| Mitsubishi Electric | 3.36% | $2.07M | ¥12.22T | 113.32% | 72 Outperform | |
| Rexel SA | 3.25% | $2.01M | €11.04B | 42.07% | 65 Neutral | |
| Nordea Bank Abp | 3.03% | $1.87M | kr605.78B | 62.02% | ― | |
| AstraZeneca | 3.02% | $1.86M | £229.75B | 26.56% | 80 Outperform |